• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化的 ChIP-seq 方法有助于人类肿瘤中转录因子的分析。

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors.

机构信息

Divisions of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.

出版信息

Life Sci Alliance. 2018 Dec 28;2(1):e201800115. doi: 10.26508/lsa.201800115. eCollection 2019 Feb.

DOI:10.26508/lsa.201800115
PMID:30620009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6311467/
Abstract

Chromatin immunoprecipitation (ChIP)-seq analyses of transcription factors in clinical specimens are challenging due to the technical limitations and low quantities of starting material, often resulting in low enrichments and poor signal-to-noise ratio. Here, we present an optimized protocol for transcription factor ChIP-seq analyses in human tissue, yielding an ∼100% success rate for all transcription factors analyzed. As proof of concept and to illustrate general applicability of the approach, human tissue from the breast, prostate, and endometrial cancers were analyzed. In addition to standard formaldehyde fixation, disuccinimidyl glutarate was included in the procedure, greatly increasing data quality. To illustrate the sensitivity of the optimized protocol, we provide high-quality ChIP-seq data for three independent factors (AR, FOXA1, and H3K27ac) from a single core needle prostate cancer biopsy specimen. In summary, double-cross-linking strongly improved transcription factor ChIP-seq quality on human tumor samples, further facilitating and enhancing translational research on limited amounts of tissue.

摘要

由于技术限制和起始材料数量少,临床标本中的染色质免疫沉淀(ChIP)-seq 分析转录因子具有挑战性,通常导致低富集度和低信噪比。在这里,我们提出了一种优化的人类组织转录因子 ChIP-seq 分析方案,所有分析的转录因子的成功率约为 100%。作为概念验证,并说明该方法的一般适用性,分析了来自乳腺癌、前列腺癌和子宫内膜癌的人类组织。除了标准的甲醛固定外,双琥珀酰亚胺戊二酸酯也包含在该程序中,极大地提高了数据质量。为了说明优化方案的灵敏度,我们提供了来自单个核心针前列腺癌活检标本的三个独立因子(AR、FOXA1 和 H3K27ac)的高质量 ChIP-seq 数据。总之,双链交联强烈改善了人类肿瘤样本中转录因子 ChIP-seq 的质量,进一步促进和增强了对有限数量组织的转化研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/d6ec21bed634/LSA-2018-00115_FigS18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/51eb0702e543/LSA-2018-00115_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/99357059fbaf/LSA-2018-00115_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/0de0d88f2085/LSA-2018-00115_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/7026c4d6cc45/LSA-2018-00115_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/e0960e5bc7b9/LSA-2018-00115_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/1f04e828096d/LSA-2018-00115_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/4c43aba0131b/LSA-2018-00115_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/1944128c378a/LSA-2018-00115_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/b044b196bb8d/LSA-2018-00115_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/cf0d7d376af6/LSA-2018-00115_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/65724fea37ef/LSA-2018-00115_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/b9f486ab773a/LSA-2018-00115_FigS7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/841fb44e89ba/LSA-2018-00115_FigS8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/a5e52f6baa16/LSA-2018-00115_FigS9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/a10bc363291d/LSA-2018-00115_FigS10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/34c32bf41730/LSA-2018-00115_FigS11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/c87878b070af/LSA-2018-00115_FigS12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/8f47db177755/LSA-2018-00115_FigS13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/2625caab57fa/LSA-2018-00115_FigS14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/041cb60a45f9/LSA-2018-00115_FigS15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/11fb7dea8482/LSA-2018-00115_FigS16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/14520325fb1c/LSA-2018-00115_FigS17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/370d38e7c508/LSA-2018-00115_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/d6ec21bed634/LSA-2018-00115_FigS18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/51eb0702e543/LSA-2018-00115_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/99357059fbaf/LSA-2018-00115_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/0de0d88f2085/LSA-2018-00115_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/7026c4d6cc45/LSA-2018-00115_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/e0960e5bc7b9/LSA-2018-00115_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/1f04e828096d/LSA-2018-00115_FigS4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/4c43aba0131b/LSA-2018-00115_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/1944128c378a/LSA-2018-00115_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/b044b196bb8d/LSA-2018-00115_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/cf0d7d376af6/LSA-2018-00115_FigS5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/65724fea37ef/LSA-2018-00115_FigS6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/b9f486ab773a/LSA-2018-00115_FigS7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/841fb44e89ba/LSA-2018-00115_FigS8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/a5e52f6baa16/LSA-2018-00115_FigS9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/a10bc363291d/LSA-2018-00115_FigS10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/34c32bf41730/LSA-2018-00115_FigS11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/c87878b070af/LSA-2018-00115_FigS12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/8f47db177755/LSA-2018-00115_FigS13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/2625caab57fa/LSA-2018-00115_FigS14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/041cb60a45f9/LSA-2018-00115_FigS15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/11fb7dea8482/LSA-2018-00115_FigS16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/14520325fb1c/LSA-2018-00115_FigS17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/370d38e7c508/LSA-2018-00115_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6eb/6311467/d6ec21bed634/LSA-2018-00115_FigS18.jpg

相似文献

1
Optimized ChIP-seq method facilitates transcription factor profiling in human tumors.优化的 ChIP-seq 方法有助于人类肿瘤中转录因子的分析。
Life Sci Alliance. 2018 Dec 28;2(1):e201800115. doi: 10.26508/lsa.201800115. eCollection 2019 Feb.
2
A novel transcriptional network for the androgen receptor in human epididymis epithelial cells.人附睾上皮细胞中雄激素受体的新型转录网络。
Mol Hum Reprod. 2018 Sep 1;24(9):433-443. doi: 10.1093/molehr/gay029.
3
High Quality ATAC-Seq Data Recovered from Cryopreserved Breast Cell Lines and Tissue.从冷冻的乳腺细胞系和组织中获得高质量的 ATAC-Seq 数据。
Sci Rep. 2019 Jan 24;9(1):516. doi: 10.1038/s41598-018-36927-7.
4
Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.AP-1在前列腺成纤维细胞雄激素受体顺反子组中的细胞谱系特异性及作用
Mol Cell Endocrinol. 2017 Jan 5;439:261-272. doi: 10.1016/j.mce.2016.09.010. Epub 2016 Sep 12.
5
Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.整合基因表达的帽分析和染色质免疫沉淀分析阵列揭示了前列腺癌细胞中的全基因组雄激素受体信号。
Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4.
6
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.FiTAc-seq:用于福尔马林固定石蜡包埋(FFPE)组织的H3K27ac谱分析和超级增强子分析的固定组织染色质免疫沉淀测序(ChIP-seq)
Nat Protoc. 2020 Aug;15(8):2503-2518. doi: 10.1038/s41596-020-0340-6. Epub 2020 Jun 26.
7
A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.一种基于载体辅助的 ChIP-seq 方法,用于从乳腺癌核心针活检样本中研究雌激素受体-染色质相互作用。
BMC Genomics. 2013 Apr 8;14:232. doi: 10.1186/1471-2164-14-232.
8
A parallelized, automated platform enabling individual or sequential ChIP of histone marks and transcription factors.一个并行化的自动化平台,可实现组蛋白标记和转录因子的单独或顺序染色质免疫沉淀。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13828-13838. doi: 10.1073/pnas.1913261117. Epub 2020 May 27.
9
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.叉头框蛋白A1(FOXA1)调节EAF2对前列腺癌细胞中雄激素受体(AR)转录活性、细胞增殖和迁移的调控。
Prostate. 2015 Jun 15;75(9):976-87. doi: 10.1002/pros.22982. Epub 2015 Mar 23.
10
TAF-ChIP: an ultra-low input approach for genome-wide chromatin immunoprecipitation assay.TAF-ChIP:一种用于全基因组染色质免疫沉淀分析的超低输入方法。
Life Sci Alliance. 2019 Jul 22;2(4). doi: 10.26508/lsa.201900318. Print 2019 Aug.

引用本文的文献

1
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination.TRIM33缺失会降低雄激素受体转录输出和H2BK120泛素化。
Commun Biol. 2025 Jul 11;8(1):1043. doi: 10.1038/s42003-025-08449-2.
2
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.表观遗传学分析确定了转移性去势抵抗性前列腺癌的内分泌抵抗标志物和治疗选择。
Cell Rep Med. 2025 Jul 15;6(7):102215. doi: 10.1016/j.xcrm.2025.102215. Epub 2025 Jul 2.
3
Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations.

本文引用的文献

1
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer.增强子图谱揭示了 luminal 型乳腺癌患者的表型异质性和演化。
Nat Med. 2018 Sep;24(9):1469-1480. doi: 10.1038/s41591-018-0091-x. Epub 2018 Jul 23.
2
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.表征男性和女性乳腺癌中类固醇激素受体的染色质结合图谱。
Nat Commun. 2018 Feb 2;9(1):482. doi: 10.1038/s41467-018-02856-2.
3
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis.
子宫内膜肿瘤发生涉及界定非编码体细胞突变和三维基因组改变的表观遗传可塑性。
Genome Biol. 2025 May 9;26(1):124. doi: 10.1186/s13059-025-03596-5.
4
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌中雄激素受体信号抑制剂耐药的基因组和转录组特征。
J Clin Invest. 2024 Aug 13;134(19):e178604. doi: 10.1172/JCI178604.
5
Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance.孕激素驱动的 B7-H4 有助于肿瘤-胎儿免疫耐受。
Cell. 2024 Aug 22;187(17):4713-4732.e19. doi: 10.1016/j.cell.2024.06.012. Epub 2024 Jul 4.
6
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing.染色质背景依赖的表观遗传药物对 CRISPR-Cas9 编辑的影响。
Nucleic Acids Res. 2024 Aug 27;52(15):8815-8832. doi: 10.1093/nar/gkae570.
7
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.雌激素受体 1 染色质在人乳腺肿瘤中的特征分析揭示了高的患者间异质性,并且在大多数保守区域富集了风险 SNPs 和增强子活性。
Genome Res. 2024 May 15;34(4):539-555. doi: 10.1101/gr.278680.123.
8
Rescuing biologically relevant consensus regions across replicated samples.跨复制样本拯救生物学相关的一致性区域。
BMC Bioinformatics. 2023 Jun 7;24(1):240. doi: 10.1186/s12859-023-05340-x.
9
Low Gut Microbial Diversity Augments Estrogen-Driven Pulmonary Fibrosis in Female-Predominant Interstitial Lung Disease.肠道低微生物多样性加剧女性为主的特发性间质性肺病中雌激素驱动的肺纤维化。
Cells. 2023 Feb 28;12(5):766. doi: 10.3390/cells12050766.
10
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.MYC 通过抑制干扰素信号促进三阴性乳腺癌的免疫抑制。
Nat Commun. 2022 Nov 2;13(1):6579. doi: 10.1038/s41467-022-34000-6.
内源性雄激素受体蛋白质组学分析揭示了前列腺肿瘤发生中涉及的基因组亚复合物。
Oncogene. 2018 Jan 18;37(3):313-322. doi: 10.1038/onc.2017.330. Epub 2017 Sep 18.
4
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.TMPRSS2-ERG 融合共同募集主转录因子并在原发性前列腺癌中激活 NOTCH 信号通路。
Nat Genet. 2017 Sep;49(9):1336-1345. doi: 10.1038/ng.3930. Epub 2017 Aug 7.
5
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.新型雄激素受体共调节因子GRHL2在前列腺癌中发挥致癌和抗转移功能。
Cancer Res. 2017 Jul 1;77(13):3417-3430. doi: 10.1158/0008-5472.CAN-16-1616. Epub 2017 May 4.
6
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors.雌激素受体α在形态相似的子宫内膜肿瘤之间发挥着治疗特异性增强子的作用。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1316-E1325. doi: 10.1073/pnas.1615233114. Epub 2017 Feb 6.
7
deepTools2: a next generation web server for deep-sequencing data analysis.深度工具2:用于深度测序数据分析的下一代网络服务器。
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5. doi: 10.1093/nar/gkw257. Epub 2016 Apr 13.
8
Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions.类固醇受体通过动态染色质转变对FoxA1占据情况进行重编程。
Cell. 2016 Apr 21;165(3):593-605. doi: 10.1016/j.cell.2016.02.067. Epub 2016 Apr 7.
9
The first decade of estrogen receptor cistromics in breast cancer.乳腺癌雌激素受体顺反组学的第一个十年。
J Endocrinol. 2016 May;229(2):R43-56. doi: 10.1530/JOE-16-0003. Epub 2016 Feb 23.
10
RIME proteomics of estrogen and progesterone receptors in breast cancer.乳腺癌中雌激素和孕激素受体的RIME蛋白质组学
Data Brief. 2015 Sep 3;5:276-80. doi: 10.1016/j.dib.2015.08.019. eCollection 2015 Dec.